NCT02702739View on ClinicalTrials.gov

Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Liver Cirrhosis
Interventions
DRUG

Sofosbuvir 400mg/day/Simeprevir 150mg/day /Ribavirin 800mg/day for 12 weeks

Sofosbuvir 400 mg/day/Simeprevir 150 mg/day /Ribavirin 800/day for 12 weeks

Trial Locations (1)

00142

AO San Camillo Forlanini, Rome

All Listed Sponsors
lead

Azienda Ospedaliera San Camillo Forlanini

OTHER

NCT02702739 - Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients | Biotech Hunter | Biotech Hunter